Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
NARI
|
Gilde Healthcare Iv U.A. Cooperatieve
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 216,192 Reduced 1.05% |
$15,436,109
$71.4 p/Share
|
Dec 18
2020 |
NTRA
|
Michael Burkes Brophy
CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 12,500 Added 14.94% |
-
|
Dec 18
2020 |
NTRA
|
Steven Leonard Chapman
CEO AND PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct | 9,375 Added 19.84% |
-
|
Dec 18
2020 |
NTRA
|
Robert Alan Schueren
CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 12,500 Added 18.42% |
-
|
Dec 18
2020 |
ARWR
|
Christopher Richard Anzalone
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 40,510 Added 1.57% |
$220,779
$5.45 p/Share
|
Dec 18
2020 |
RPD
|
Thomas E Schodorf
Director |
SELL
Open market or private sale
|
Direct | 1,750 Reduced 6.63% |
$145,250
$83.0 p/Share
|
Dec 18
2020 |
RPD
|
Thomas E Schodorf
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 840 Added 3.08% |
$10,802
$12.86 p/Share
|
Dec 18
2020 |
HELE
|
Julien Mininberg
Chief Executive Officer |
BUY
Bona fide gift
|
Indirect | 48,436 Added 50.0% |
-
|
Dec 18
2020 |
HELE
|
Julien Mininberg
Chief Executive Officer |
SELL
Bona fide gift
|
Indirect | 48,436 Reduced 50.0% |
-
|
Dec 18
2020 |
LYFT
|
David Lawee |
SELL
Open market or private sale
|
Indirect | 207,455 Reduced 1.75% |
$10,376,899
$50.02 p/Share
|
Dec 18
2020 |
TENB
|
Kimberly Hammonds
Director |
SELL
Open market or private sale
|
Direct | 14,239 Reduced 100.0% |
$657,415
$46.17 p/Share
|
Dec 18
2020 |
RUN
|
David Bywater
Director |
SELL
Open market or private sale
|
Direct | 263,328 Reduced 46.28% |
$16,834,559
$63.93 p/Share
|
Dec 18
2020 |
RUN
|
David Bywater
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 263,328 Added 31.64% |
$2,406,818
$9.14 p/Share
|
Dec 18
2020 |
RUN
|
Edward Harris Fenster
Director |
SELL
Open market or private sale
|
Direct | 11,964 Reduced 0.75% |
$747,630
$62.49 p/Share
|
Dec 18
2020 |
RUN
|
Jeanna Steele
Chief Legal & People Officer |
SELL
Open market or private sale
|
Direct | 60,839 Reduced 44.62% |
$3,817,039
$62.74 p/Share
|
Dec 18
2020 |
RUN
|
Jeanna Steele
Chief Legal & People Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 58,354 Added 29.97% |
$704,916
$12.08 p/Share
|
Dec 18
2020 |
MNDT
|
Alexa King
EVP and General Counsel |
SELL
Open market or private sale
|
Direct | 43,659 Reduced 9.4% |
$785,862
$18.0 p/Share
|
Dec 18
2020 |
MNDT
|
William T Robbins
EVP & CRO |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 23.14% |
$1,751,000
$17.51 p/Share
|
Dec 18
2020 |
FIVE
|
Ronald Sargent
Director |
SELL
Open market or private sale
|
Indirect | 20,000 Reduced 4.6% |
$3,191,800
$159.59 p/Share
|
Dec 18
2020 |
FLEX
|
Francois Barbier
Group President |
SELL
Open market or private sale
|
Direct | 57,255 Reduced 8.5% |
$977,915
$17.08 p/Share
|
Dec 18
2020 |
EXEL
|
Peter Lamb
EVP, Scientific Strategy & CSO |
SELL
Open market or private sale
|
Direct | 65,000 Reduced 18.67% |
$1,300,650
$20.01 p/Share
|
Dec 18
2020 |
EXEL
|
Peter Lamb
EVP, Scientific Strategy & CSO |
BUY
Exercise of conversion of derivative security
|
Direct | 65,000 Added 15.73% |
$110,500
$1.7 p/Share
|
Dec 18
2020 |
AN
|
Robert R Grusky
Director |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 10.06% |
$350,000
$70.0 p/Share
|
Dec 18
2020 |
AN
|
Robert R Grusky
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 5,000 Added 9.14% |
$170,450
$34.09 p/Share
|
Dec 18
2020 |
NVCR
|
Asaf Danziger |
SELL
Open market or private sale
|
Direct | 207,910 Reduced 51.27% |
$33,369,555
$160.5 p/Share
|
Dec 18
2020 |
NVCR
|
Asaf Danziger |
BUY
Exercise of conversion of derivative security
|
Direct | 207,910 Added 40.81% |
$4,574,020
$22.0 p/Share
|
Dec 18
2020 |
NVCR
|
Jeryl L Hilleman |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 42.37% |
$416,000
$166.4 p/Share
|
Dec 18
2020 |
ZION
|
Bruce K Alexander
Exec VP and |
SELL
Payment of exercise price or tax liability
|
Direct | 126 Reduced 0.62% |
$5,049
$40.07 p/Share
|
Dec 18
2020 |
ZION
|
A Scott Anderson
Exec VP and |
SELL
Payment of exercise price or tax liability
|
Direct | 278 Reduced 0.99% |
$11,139
$40.07 p/Share
|
Dec 18
2020 |
ZION
|
David E Blackford
Exec Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 301 Reduced 1.52% |
$12,061
$40.07 p/Share
|
Dec 18
2020 |
ZION
|
Alan M Forney
Exec VP & Division CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 136 Reduced 0.96% |
$5,450
$40.07 p/Share
|
Dec 18
2020 |
ZION
|
Michael Morris
Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 175 Reduced 0.78% |
$7,012
$40.07 p/Share
|
Dec 18
2020 |
ZION
|
Edward Schreiber
Chief Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 305 Reduced 0.72% |
$12,221
$40.07 p/Share
|
Dec 18
2020 |
ZION
|
Steven Dan Stephens
Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 244 Reduced 0.42% |
$9,777
$40.07 p/Share
|
Dec 18
2020 |
ZION
|
Randy R Stewart
Exec VP |
SELL
Payment of exercise price or tax liability
|
Direct | 95 Reduced 1.05% |
$3,807
$40.07 p/Share
|
Dec 18
2020 |
ZION
|
Mark Richard Young
Exec VP |
SELL
Payment of exercise price or tax liability
|
Direct | 138 Reduced 1.47% |
$5,530
$40.07 p/Share
|
Dec 18
2020 |
TTC
|
Blake M Grams
VP, Strategy, Corp Dev & Sust |
SELL
Open market or private sale
|
Direct | 1,094 Reduced 100.0% |
$103,481
$94.59 p/Share
|
Dec 18
2020 |
CBSH
|
Jonathan M Kemper
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 630 Added 0.4% |
$40,389
$64.11 p/Share
|
Dec 18
2020 |
CBSH
|
Kevin G Barth
Executive Vice President |
BUY
Grant, award, or other acquisition
|
Indirect | 68 Added 0.39% |
$4,359
$64.11 p/Share
|
Dec 18
2020 |
CBSH
|
Daniel D. Callahan
Exec. Vice President & CCO |
BUY
Grant, award, or other acquisition
|
Indirect | 2 Added 0.52% |
$128
$64.11 p/Share
|
Dec 18
2020 |
BJ
|
Jeff Desroches
EVP, Chief Operations Officer |
SELL
Open market or private sale
|
Direct | 80,596 Reduced 37.35% |
$3,086,021
$38.29 p/Share
|
Dec 18
2020 |
BJ
|
Jeff Desroches
EVP, Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 47,250 Added 17.96% |
$270,270
$5.72 p/Share
|
Dec 18
2020 |
ACM
|
Daniel R. Tishman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,078 Added 3.42% |
-
|
Dec 18
2020 |
ACM
|
Lara Poloni
PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct | 4,959 Added 21.6% |
-
|
Dec 18
2020 |
ACM
|
Gaurav Kapoor
CHIEF FINANCIAL OFFICER (PAO) |
BUY
Grant, award, or other acquisition
|
Direct | 2,841 Added 14.93% |
-
|
Dec 18
2020 |
ACM
|
Troy Rudd
CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 17,046 Added 14.16% |
-
|
Dec 18
2020 |
UHAL
|
Willow Grove Holdings LP |
BUY
Open market or private purchase
|
Indirect | 45 Added 0.01% |
$20,215
$449.22 p/Share
|
Dec 18
2020 |
UHAL
|
Edward J Shoen
President |
BUY
Open market or private purchase
|
Indirect | 45 Added 0.0% |
$20,215
$449.22 p/Share
|
Dec 18
2020 |
UHAL
|
Mark V Shoen |
BUY
Open market or private purchase
|
Indirect | 45 Added 0.0% |
$20,215
$449.22 p/Share
|
Dec 18
2020 |
DT
|
Paul Andrew Zuber
Director |
SELL
Open market or private sale
|
Indirect | 7,400 Reduced 29.01% |
$326,784
$44.16 p/Share
|
Dec 18
2020 |